ChromoCure, Inc. (KKUR.PK) Announces Co-Development Agreement for Nationwide Distribution of New CS300 Cancer Scanner Series
ChromoCure, Inc., a developer and provider of proprietary cancer detection systems, recently announced a co-development agreement with the company’s primary cell preparation and application technology supplier. Under the terms of the agreement, ChromoCure will co-develop a fully integrated chromosomal scanner system for nationwide distribution to pathology and related cancer detection labs. ChromoCure will collaborate with companies and joint technical research and development efforts to complete a fully automated hybridization system allowing for a complete chromosomal scanning solution. The CS300 system has the ability to perform a full 23-pair chromosomal cross-sectioning for every cell within a sample, while integrating solid tumor…